ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension

Pulmonary hypertension (PH) is a cardiovascular disease caused by extensive vascular remodeling in the lungs, which ultimately leads to death in consequence of right ventricle (RV) failure. While current drugs for PH therapy address the sustained vasoconstriction, no agent effectively targets vascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Montagnoli, Tadeu L., da Silva, Jaqueline S., Sudo, Susumu Z., Santos, Aimeé D., Gomide, Gabriel F., de Sá, Mauro P. L., Zapata-Sudo, Gisele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303917/
https://www.ncbi.nlm.nih.gov/pubmed/34209333
http://dx.doi.org/10.3390/cells10071648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303917/
https://www.ncbi.nlm.nih.gov/pubmed/34209333
http://dx.doi.org/10.3390/cells10071648

Ejemplares similares